{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T11:01:17Z","timestamp":1792839677176,"version":"4.5.0"},"reference-count":85,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,5,4]],"date-time":"2023-05-04T00:00:00Z","timestamp":1683158400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000921","name":"European Cooperation in Science and Technology","doi-asserted-by":"publisher","award":["CA-17112"],"award-info":[{"award-number":["CA-17112"]}],"id":[{"id":"10.13039\/501100000921","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000282","name":"Sir Jules Thorn Charitable Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000282","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009473","name":"Universidad de M\u00e1laga","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009473","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Carlos III Health Institute","doi-asserted-by":"publisher","award":["PT20\/00127"],"award-info":[{"award-number":["PT20\/00127"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journal-of-hepatology.eu","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Hepatology"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.jhep.2023.04.033","type":"journal-article","created":{"date-parts":[[2023,5,8]],"date-time":"2023-05-08T11:25:10Z","timestamp":1683545110000},"page":"853-866","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":162,"title":["Nomenclature, diagnosis and management of drug-induced autoimmune-like hepatitis (DI-ALH): An expert opinion meeting report"],"prefix":"10.1016","volume":"79","author":[{"given":"Ra\u00fal J.","family":"Andrade","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3924-4830","authenticated-orcid":false,"given":"Guruprasad P.","family":"Aithal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4066-7593","authenticated-orcid":false,"given":"Ynto S.","family":"de Boer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodrigo","family":"Liberal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0440-7417","authenticated-orcid":false,"given":"Alexander","family":"Gerbes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arie","family":"Regev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benedetta","family":"Terziroli Beretta-Piccoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4264-1928","authenticated-orcid":false,"given":"Christoph","family":"Schramm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3442-4453","authenticated-orcid":false,"given":"David E.","family":"Kleiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleonora","family":"De Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0757-4408","authenticated-orcid":false,"given":"Gerd A.","family":"Kullak-Ublick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8215-4489","authenticated-orcid":false,"given":"Guido","family":"Stirnimann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3593-3746","authenticated-orcid":false,"given":"Harshad","family":"Devarbhavi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John M.","family":"Vierling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael P.","family":"Manns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5163-6979","authenticated-orcid":false,"given":"Marcial","family":"Sebode","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Carlota","family":"Londo\u00f1o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Avigan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2365-2787","authenticated-orcid":false,"given":"Mercedes","family":"Robles-Diaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miren","family":"Garc\u00eda-Cortes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7341-9174","authenticated-orcid":false,"given":"Edmond","family":"Atallah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Heneghan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naga","family":"Chalasani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Palak J.","family":"Trivedi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5371-1020","authenticated-orcid":false,"given":"Paul H.","family":"Hayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9270-2496","authenticated-orcid":false,"given":"Richard","family":"Taubert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert J.","family":"Fontana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7077-8078","authenticated-orcid":false,"given":"Sabine","family":"Weber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0495-6734","authenticated-orcid":false,"given":"Ye Htun","family":"Oo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8370-6508","authenticated-orcid":false,"given":"Yoh","family":"Zen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Licata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M Isabel","family":"Lucena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgina","family":"Mieli-Vergani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diego","family":"Vergani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Einar S.","family":"Bj\u00f6rnsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.jhep.2023.04.033_bib1","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1038\/s41572-019-0105-0","article-title":"Drug-induced liver injury","volume":"5","author":"Andrade","year":"2019","journal-title":"Nat Rev Dis Primers"},{"issue":"6","key":"10.1016\/j.jhep.2023.04.033_bib2","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1016\/j.jhep.2019.02.014","article-title":"EASL clinical practice guidelines: drug-induced liver injury","volume":"70","year":"2019","journal-title":"J\u00a0Hepatol"},{"issue":"5","key":"10.1016\/j.jhep.2023.04.033_bib3","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1111\/liv.15217","volume":"42","author":"Lohse","year":"2022","journal-title":"Liver Int"},{"issue":"4","key":"10.1016\/j.jhep.2023.04.033_bib4","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1007\/s10620-011-1611-4","article-title":"Drug-induced autoimmune-like hepatitis","volume":"56","author":"Czaja","year":"2011","journal-title":"Dig Dis Sci"},{"issue":"2","key":"10.1016\/j.jhep.2023.04.033_bib5","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1002\/hep.31065","article-title":"Diagnosis and management of autoimmune hepatitis in adults and children: 2019 practice guidance and guidelines from the American association for the study of liver diseases","volume":"72","author":"Mack","year":"2020","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.jhep.2023.04.033_bib6","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/j.jhep.2015.06.030","article-title":"EASL clinical practice guidelines: autoimmune hepatitis","volume":"63","year":"2015","journal-title":"J\u00a0Hepatol"},{"issue":"4","key":"10.1016\/j.jhep.2023.04.033_bib7","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/j.jhep.2010.12.041","article-title":"Recurrent drug-induced liver injury (DILI) with different drugs in the Spanish Registry: the dilemma of the relationship to autoimmune hepatitis","volume":"55","author":"Lucena","year":"2011","journal-title":"J\u00a0Hepatol"},{"issue":"1","key":"10.1016\/j.jhep.2023.04.033_bib8","article-title":"Histological and serological features of acute liver injury after SARS-CoV-2 vaccination","volume":"5","author":"Codoni","year":"2023","journal-title":"JHEP Rep"},{"issue":"2","key":"10.1016\/j.jhep.2023.04.033_bib9","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1093\/aje\/kwab119","article-title":"Cancer risk in patients with autoimmune hepatitis: a nationwide population-based cohort study with histopathology","volume":"191","author":"Sharma","year":"2022","journal-title":"Am J Epidemiol"},{"issue":"1","key":"10.1016\/j.jhep.2023.04.033_bib10","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1111\/liv.15378","article-title":"A\u00a0new framework for advancing in drug-induced liver injury research. The Prospective European DILI Registry","volume":"43","author":"Bj\u00f6rnsson","year":"2023","journal-title":"Liver Int"},{"issue":"4","key":"10.1016\/j.jhep.2023.04.033_bib11","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/j.jhep.2021.12.041","article-title":"Systematic review of response criteria and endpoints in autoimmune hepatitis by the International Autoimmune Hepatitis Group","volume":"76","author":"Pape","year":"2022","journal-title":"J\u00a0Hepatol"},{"issue":"10","key":"10.1016\/j.jhep.2023.04.033_bib12","doi-asserted-by":"crossref","first-page":"2396","DOI":"10.1111\/liv.14944","article-title":"Environmental risk factors are associated with autoimmune hepatitis","volume":"41","author":"Lammert","year":"2021","journal-title":"Liver Int"},{"issue":"3","key":"10.1016\/j.jhep.2023.04.033_bib13","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1056\/NEJMra1816149","article-title":"Drug-induced liver injury - types and phenotypes","volume":"381","author":"Hoofnagle","year":"2019","journal-title":"N\u00a0Engl J Med"},{"issue":"6","key":"10.1016\/j.jhep.2023.04.033_bib14","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1002\/hep.23588","article-title":"Drug-induced autoimmune hepatitis: clinical characteristics and prognosis","volume":"51","author":"Bj\u00f6rnsson","year":"2010","journal-title":"Hepatology"},{"issue":"12","key":"10.1016\/j.jhep.2023.04.033_bib15","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1016\/j.cgh.2016.07.022","article-title":"Characterizing drug-induced liver injury with autoimmune features","volume":"14","author":"Andrade","year":"2016","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"3","key":"10.1016\/j.jhep.2023.04.033_bib16","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1002\/hep.24481","article-title":"The use of liver biopsy evaluation in discrimination of idiopathic autoimmune hepatitis versus drug-induced liver injury","volume":"54","author":"Suzuki","year":"2011","journal-title":"Hepatology"},{"issue":"10","key":"10.1016\/j.jhep.2023.04.033_bib17","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1016\/j.cgh.2017.05.027","article-title":"Drug-induced autoimmune hepatitis: response to corticosteroids and lack of relapse after cessation of steroids","volume":"15","author":"Bj\u00f6rnsson","year":"2017","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"1","key":"10.1016\/j.jhep.2023.04.033_bib18","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.jhep.2021.01.029","article-title":"Comprehensive analysis and insights gained from long-term experience of the Spanish DILI Registry","volume":"75","author":"Stephens","year":"2021","journal-title":"J\u00a0Hepatol"},{"issue":"4","key":"10.1016\/j.jhep.2023.04.033_bib19","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/j.jhep.2011.02.024","article-title":"Drug induced liver injury and its relationship to autoimmune hepatitis","volume":"55","author":"Weiler-Normann","year":"2011","journal-title":"J\u00a0Hepatol"},{"issue":"2","key":"10.1016\/j.jhep.2023.04.033_bib20","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1055\/s-0034-1375959","article-title":"Drug-induced liver injury with autoimmune features","volume":"34","author":"deLemos","year":"2014","journal-title":"Semin Liver Dis"},{"issue":"8","key":"10.1016\/j.jhep.2023.04.033_bib21","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1002\/hep4.1959","article-title":"Setting up criteria for drug-induced autoimmune-like hepatitis through a systematic analysis of published report","volume":"6","author":"Bj\u00f6rnsson","year":"2022","journal-title":"Hepatol Commun"},{"issue":"3","key":"10.1016\/j.jhep.2023.04.033_bib22","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/S1089-3261(02)00025-9","article-title":"Immune-mediated drug-induced liver disease","volume":"6","author":"Liu","year":"2002","journal-title":"Clin Liver Dis"},{"issue":"1","key":"10.1016\/j.jhep.2023.04.033_bib23","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/s12072-011-9277-8","article-title":"Clinical significance of serum autoantibodies in patients with NAFLD: results from the nonalcoholic steatohepatitis clinical research network","volume":"6","author":"Vuppalanchi","year":"2012","journal-title":"Hepatol Int"},{"issue":"1","key":"10.1016\/j.jhep.2023.04.033_bib24","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.cgh.2016.05.043","article-title":"Features of autoimmune hepatitis in patients with drug-induced liver injury","volume":"15","author":"de Boer","year":"2017","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"2","key":"10.1016\/j.jhep.2023.04.033_bib25","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1007\/s12072-021-10144-3","article-title":"Drug-induced liver injury: asia pacific association of study of liver consensus guidelines","volume":"15","author":"Devarbhavi","year":"2021","journal-title":"Hepatol Int"},{"issue":"5","key":"10.1016\/j.jhep.2023.04.033_bib26","doi-asserted-by":"crossref","first-page":"878","DOI":"10.14309\/ajg.0000000000001259","article-title":"Practice parameters committee of the American College of Gastroenterology. ACG clinical guideline: diagnosis and management of idiosyncratic drug-induced liver injury","volume":"116","author":"Chalasani","year":"2021","journal-title":"Am J Gastroenterol"},{"issue":"3","key":"10.1016\/j.jhep.2023.04.033_bib27","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1002\/hep.32689","article-title":"AASLD practice guidance on drug, herbal, and dietary supplement-induced liver injury","volume":"77","author":"Fontana","year":"2023","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.jhep.2023.04.033_bib28","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1002\/hep.27983","article-title":"Prediction of short- and long-term outcome in patients with autoimmune hepatitis","volume":"62","author":"Kirstein","year":"2015","journal-title":"Hepatology"},{"issue":"10","key":"10.1016\/j.jhep.2023.04.033_bib29","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1111\/jgh.14746","article-title":"Systematic review and meta-analysis on the incidence and prevalence of autoimmune hepatitis in Asian, European, and American population","volume":"34","author":"Lv","year":"2019","journal-title":"J\u00a0Gastroenterol Hepatol"},{"issue":"2","key":"10.1016\/j.jhep.2023.04.033_bib30","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1053\/jhep.2002.34857","article-title":"Incidence of drug-induced hepatic injuries: a French population-based study","volume":"36","author":"Sgro","year":"2002","journal-title":"Hepatology"},{"issue":"7","key":"10.1016\/j.jhep.2023.04.033_bib31","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1053\/j.gastro.2013.02.006","article-title":"Incidence, presentation, and outcomes in patients with drug-induced liver injury in the general population of Iceland","volume":"144","author":"Bj\u00f6rnsson","year":"2013","journal-title":"Gastroenterology"},{"issue":"12","key":"10.1016\/j.jhep.2023.04.033_bib32","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1016\/j.dld.2014.08.040","article-title":"Clinical features and outcomes of patients with drug-induced autoimmune hepatitis: a retrospective cohort study","volume":"46","author":"Licata","year":"2014","journal-title":"Dig Liver Dis"},{"issue":"3","key":"10.1016\/j.jhep.2023.04.033_bib33","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/S0168-8278(87)80039-9","article-title":"Chronic active hepatitis caused by benzarone","volume":"5","author":"Babany","year":"1987","journal-title":"J\u00a0Hepatol"},{"issue":"24","key":"10.1016\/j.jhep.2023.04.033_bib34","doi-asserted-by":"crossref","first-page":"7584","DOI":"10.3748\/wjg.v21.i24.7584","article-title":"Autoimmune hepatitis and anti-tumor necrosis factor alpha therapy:\u00a0a single center report of 8 cases","volume":"21","author":"Rodrigues","year":"2015","journal-title":"World J Gastroenterol"},{"issue":"5","key":"10.1016\/j.jhep.2023.04.033_bib35","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.cgh.2012.12.025","article-title":"Liver injury from tumor necrosis factor-alpha antagonists: analysis of thirty-four cases","volume":"11","author":"Ghabril","year":"2013","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"10","key":"10.1016\/j.jhep.2023.04.033_bib36","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.3109\/00365521.2014.946083","article-title":"Epidemiology and clinical characteristics of autoimmune\u00a0hepatitis in The Netherlands","volume":"49","author":"van Gerven","year":"2014","journal-title":"Scand J Gastroenterol"},{"issue":"1","key":"10.1016\/j.jhep.2023.04.033_bib37","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S1089-3261(05)70097-0","article-title":"Drug-induced liver disease","volume":"4","author":"Zimmerman","year":"2000","journal-title":"Clin Liver Dis"},{"issue":"32","key":"10.1016\/j.jhep.2023.04.033_bib38","article-title":"Prescription event monitoring of checkpoint inhibitor-induced liver injury and outcomes of rechallenge: a 10-year experience","volume":"10","author":"Atallah","year":"2022","journal-title":"EMJ Hepatol"},{"issue":"1","key":"10.1016\/j.jhep.2023.04.033_bib39","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1111\/liv.15340","article-title":"Immune checkpoint inhibitor-related cholangiopathy: novel clinicopathological description of a multi-centre cohort","volume":"43","author":"Berry","year":"2023","journal-title":"Liver Int"},{"issue":"8","key":"10.1016\/j.jhep.2023.04.033_bib40","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1111\/liv.14489","article-title":"Immune-related hepatitis related to checkpoint inhibitors: clinical and prognostic factors","volume":"40","author":"Riveiro-Barciela","year":"2020","journal-title":"Liver Int"},{"issue":"11","key":"10.1016\/j.jhep.2023.04.033_bib41","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1001\/jamaoncol.2021.4342","article-title":"Utility of liver\u00a0biopsy in diagnosis and management of high-grade immune checkpoint\u00a0inhibitor hepatitis in patients with cancer","volume":"7","author":"Li","year":"2021","journal-title":"JAMA Oncol"},{"issue":"6","key":"10.1016\/j.jhep.2023.04.033_bib42","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1038\/s41379-018-0013-y","article-title":"Hepatotoxicity of immune checkpoint inhibitors: a histology study of seven cases in comparison with autoimmune hepatitis and idiosyncratic drug-induced liver injury","volume":"31","author":"Zen","year":"2018","journal-title":"Mod Pathol"},{"issue":"6","key":"10.1016\/j.jhep.2023.04.033_bib43","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1016\/j.jhep.2018.01.033","article-title":"Characterization of liver injury induced by cancer immunotherapy using immune checkpoint inhibitors","volume":"68","author":"De Martin","year":"2018","journal-title":"J\u00a0Hepatol"},{"issue":"1","key":"10.1016\/j.jhep.2023.04.033_bib44","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.jhep.2021.04.003","article-title":"Autoimmune hepatitis developing after coronavirus disease 2019 (COVID-19) vaccine: causality or casualty?","volume":"75","author":"Bril","year":"2021","journal-title":"J\u00a0Hepatol"},{"issue":"6","key":"10.1016\/j.jhep.2023.04.033_bib45","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1002\/hep.32572","article-title":"Liver injury after SARS-CoV-2 vaccination: features of immune-mediated hepatitis, role of corticosteroid therapy and outcome","volume":"76","author":"Efe","year":"2022","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.jhep.2023.04.033_bib46","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1002\/hep.22322","article-title":"Simplified criteria for the diagnosis of autoimmune hepatitis","volume":"48","author":"Hennes","year":"2008","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.jhep.2023.04.033_bib47","doi-asserted-by":"crossref","first-page":"160","DOI":"10.4254\/wjh.v6.i4.160","article-title":"Drug-induced autoimmune liver disease: a diagnostic dilemma of an increasingly reported disease","volume":"6","author":"Castiella","year":"2014","journal-title":"World J Hepatol"},{"issue":"1","key":"10.1016\/j.jhep.2023.04.033_bib48","first-page":"21","article-title":"Liver fibrosis helps to distinguish autoimmune hepatitis from DILI with autoimmune features: a review of twenty cases","volume":"7","author":"Febres-Aldana","year":"2019","journal-title":"J\u00a0Clin Transl Hepatol"},{"issue":"3","key":"10.1016\/j.jhep.2023.04.033_bib49","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/j.cgh.2014.07.062","article-title":"Risk of drug-induced liver injury from tumor necrosis factor antagonists","volume":"13","author":"Bj\u00f6rnsson","year":"2015","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"1","key":"10.1016\/j.jhep.2023.04.033_bib50","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.jhep.2021.08.024","article-title":"Infliximab-induced liver injury: clinical phenotypes, autoimmunity and the role of corticosteroid treatment","volume":"76","author":"Bj\u00f6rnsson","year":"2022","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2023.04.033_bib51","doi-asserted-by":"crossref","DOI":"10.1111\/liv.15623","article-title":"Clinical presentation, causative drugs, and outcome of patients with autoimmune features in the Spanish DILI Regsitry and the Latin American DILI Network","author":"Garc\u00eda-Cort\u00e9s","year":"2023","journal-title":"Liver Int"},{"issue":"3","key":"10.1016\/j.jhep.2023.04.033_bib52","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.jhep.2008.10.021","article-title":"The long-term follow-up after idiosyncratic drug-induced liver injury with jaundice","volume":"50","author":"Bj\u00f6rnsson","year":"2009","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2023.04.033_bib53","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.jaut.2018.10.004","article-title":"The clinical usage and definition of autoantibodies in immune-mediated liver disease: a comprehensive overview","volume":"95","author":"Terziroli Beretta-Piccoli","year":"2018","journal-title":"J\u00a0Autoimmun"},{"issue":"9","key":"10.1016\/j.jhep.2023.04.033_bib54","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1002\/art.1780400909","article-title":"Range of antinuclear antibodies in \u201chealthy\u201d individuals","volume":"40","author":"Tan","year":"1997","journal-title":"Arthritis Rheum"},{"issue":"4","key":"10.1016\/j.jhep.2023.04.033_bib55","first-page":"225","article-title":"Autoantibodies and liver disease: uses and abuses","volume":"24","author":"Zeman","year":"2010","journal-title":"Can J Gastroenterol"},{"issue":"9","key":"10.1016\/j.jhep.2023.04.033_bib56","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18091954","article-title":"\u201cAutoimmune(-Like)\u201d drug and herb induced liver injury: new insights into molecular pathogenesis","volume":"18","author":"Sebode","year":"2017","journal-title":"Int J Mol Sci"},{"issue":"9","key":"10.1016\/j.jhep.2023.04.033_bib57","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1097\/FPC.0000000000000230","article-title":"Autoantibody presentation in drug-induced liver injury and idiopathic autoimmune hepatitis: the influence of human leucocyte antigen alleles","volume":"26","author":"Stephens","year":"2016","journal-title":"Pharmacogenet Genomics"},{"issue":"3","key":"10.1016\/j.jhep.2023.04.033_bib58","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1159\/000511635","article-title":"Antimitochondrial rather than antinuclear antibodies correlate with severe drug-induced liver injury","volume":"39","author":"Weber","year":"2021","journal-title":"Dig Dis"},{"issue":"5","key":"10.1016\/j.jhep.2023.04.033_bib59","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/S0168-8278(99)80297-9","article-title":"International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis","volume":"31","author":"Alvarez","year":"1999","journal-title":"J\u00a0Hepatol"},{"issue":"3","key":"10.1016\/j.jhep.2023.04.033_bib60","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1111\/his.12558","article-title":"Assessment of the histopathological key features in autoimmune hepatitis","volume":"66","author":"de Boer","year":"2015","journal-title":"Histopathology"},{"issue":"2","key":"10.1016\/j.jhep.2023.04.033_bib61","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1002\/hep.26709","article-title":"Hepatic histological findings in suspected drug-induced liver injury: systematic evaluation and clinical associations","volume":"59","author":"Kleiner","year":"2014","journal-title":"Hepatology"},{"issue":"11","key":"10.1016\/j.jhep.2023.04.033_bib62","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1016\/0895-4356(93)90101-6","article-title":"Causality assessment of adverse reactions to drugs--I. A novel method based on the conclusions of international consensus meetings: application to drug-induced liver injuries","volume":"46","author":"Danan","year":"1993","journal-title":"J\u00a0Clin Epidemiol"},{"issue":"3","key":"10.1016\/j.jhep.2023.04.033_bib63","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.jhep.2011.02.007","article-title":"Causality assessment methods in drug induced liver injury: strengths and weaknesses","volume":"55","author":"Garcia-Cortes","year":"2011","journal-title":"J\u00a0Hepatol"},{"issue":"1","key":"10.1016\/j.jhep.2023.04.033_bib64","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1002\/hep.32327","article-title":"A revised electronic version of RUCAM for the diagnosis of DILI","volume":"76","author":"Hayashi","year":"2022","journal-title":"Hepatology"},{"issue":"11","key":"10.1016\/j.jhep.2023.04.033_bib65","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1002\/hep4.1582","article-title":"Exploratory study of autoantibody profiling in drug-induced liver injury with an autoimmune phenotype","volume":"4","author":"Lammert","year":"2020","journal-title":"Hepatol Commun"},{"issue":"1","key":"10.1016\/j.jhep.2023.04.033_bib66","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1002\/hep.32134","article-title":"Quantification of polyreactive immunoglobulin G facilitates the diagnosis of autoimmune hepatitis","volume":"75","author":"Taubert","year":"2022","journal-title":"Hepatology"},{"issue":"8","key":"10.1016\/j.jhep.2023.04.033_bib67","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1111\/apt.17373","article-title":"Potential benefit and lack of serious risk from corticosteroids in drug-induced liver injury: an international, multicentre, propensity score-matched analysis","volume":"57","author":"Niu","year":"2023","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jhep.2023.04.033_bib68","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.820724","article-title":"Role of corticosteroids in drug-induced liver injury. A systematic review","volume":"13","author":"Bj\u00f6rnsson","year":"2022","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.jhep.2023.04.033_bib69","doi-asserted-by":"crossref","DOI":"10.1016\/j.aohep.2021.100321","article-title":"Drug-induced liver injury: a management position paper from the Latin American Association for Study of the liver","volume":"24","author":"Bessone","year":"2021","journal-title":"Ann Hepatol"},{"issue":"4","key":"10.1016\/j.jhep.2023.04.033_bib70","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1111\/hepr.12530","article-title":"Clinical and histological features of idiosyncratic liver injury: dilemma in diagnosis of autoimmune hepatitis","volume":"46","author":"Kuzu","year":"2016","journal-title":"Hepatol Res"},{"issue":"3","key":"10.1016\/j.jhep.2023.04.033_bib71","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1002\/jgh3.12054","article-title":"Differential characteristics in drug-induced autoimmune hepatitis","volume":"2","author":"Martinez-Casas","year":"2018","journal-title":"JGH Open"},{"issue":"10","key":"10.1016\/j.jhep.2023.04.033_bib72","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1111\/liv.14195","article-title":"Early ALT response to corticosteroid treatment distinguishes idiosyncratic drug-induced liver injury from autoimmune hepatitis","volume":"39","author":"Weber","year":"2019","journal-title":"Liver Int"},{"issue":"2","key":"10.1016\/j.jhep.2023.04.033_bib73","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.jhep.2021.03.031","article-title":"Acute severe autoimmune hepatitis - timing for steroids and role of other immunosuppressive agents","volume":"75","author":"Liberal","year":"2021","journal-title":"J\u00a0Hepatol"},{"issue":"3","key":"10.1016\/j.jhep.2023.04.033_bib74","first-page":"122","article-title":"Corticosteroid therapy in drug-induced liver injury: pros and cons","volume":"20","author":"Hu","year":"2019","journal-title":"J\u00a0Dig Dis"},{"issue":"6","key":"10.1016\/j.jhep.2023.04.033_bib75","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1517\/14740330903397378","article-title":"Rechallenge in drug-induced liver injury: the attractive hazard","volume":"8","author":"Andrade","year":"2009","journal-title":"Expert Opin Drug Saf"},{"issue":"2","key":"10.1016\/j.jhep.2023.04.033_bib76","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1002\/hep.29152","article-title":"Drug rechallenge following drug-induced liver injury","volume":"66","author":"Hunt","year":"2017","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.jhep.2023.04.033_bib77","doi-asserted-by":"crossref","first-page":"1892","DOI":"10.1002\/hep.24513","article-title":"Seven cases of autoimmune hepatitis that developed after drug-induced liver injury","volume":"54","author":"Sugimoto","year":"2011","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.jhep.2023.04.033_bib78","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/j.jhep.2016.12.003","article-title":"EASL Clinical Practical Guidelines on the management of acute (fulminant) liver failure","volume":"66","year":"2017","journal-title":"J Hepatol"},{"issue":"1","key":"10.1016\/j.jhep.2023.04.033_bib79","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1053\/j.gastro.2014.03.050","article-title":"Use of Hy's law and a new composite algorithm to predict acute liver failure in patients with drug-induced liver injury","volume":"147","author":"Robles-Diaz","year":"2014","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1016\/j.jhep.2023.04.033_bib80","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1136\/gutjnl-2016-313369","article-title":"Drug-induced liver injury: recent advances in diagnosis and risk assessment","volume":"66","author":"Kullak-Ublick","year":"2017","journal-title":"Gut"},{"issue":"3\u20134","key":"10.1016\/j.jhep.2023.04.033_bib81","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.drudis.2008.11.009","article-title":"The future of drug safety testing: expanding the view and narrowing the focus","volume":"14","author":"Stevens","year":"2009","journal-title":"Drug Discov Today"},{"issue":"2","key":"10.1016\/j.jhep.2023.04.033_bib82","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1055\/s-0034-1375962","article-title":"Drug-induced liver injury and drug development: industry perspective","volume":"34","author":"Regev","year":"2014","journal-title":"Semin Liver Dis"},{"issue":"6","key":"10.1016\/j.jhep.2023.04.033_bib83","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1016\/j.jceh.2021.06.021","article-title":"Herbal immune booster-induced liver injury in the COVID-19 pandemic-A case series","volume":"11","author":"Nagral","year":"2021","journal-title":"J\u00a0Clin Exp Hepatol"},{"issue":"4","key":"10.1016\/j.jhep.2023.04.033_bib84","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1002\/hep4.1039","article-title":"Atovaquone\/proguanil-induced autoimmune-like hepatitis","volume":"1","author":"Terziroli Beretta-Piccoli","year":"2017","journal-title":"Hepatol Commun"},{"issue":"6","key":"10.1016\/j.jhep.2023.04.033_bib85","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1038\/clpt.2011.58","article-title":"Case definition and phenotype standardization in drug-induced liver injury","volume":"89","author":"Aithal","year":"2011","journal-title":"Clin Pharmacol Ther"}],"container-title":["Journal of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827823003203?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827823003203?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T00:56:47Z","timestamp":1777510607000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168827823003203"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":85,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["S0168827823003203"],"URL":"https:\/\/doi.org\/10.1016\/j.jhep.2023.04.033","relation":{},"ISSN":["0168-8278"],"issn-type":[{"value":"0168-8278","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nomenclature, diagnosis and management of drug-induced autoimmune-like hepatitis (DI-ALH): An expert opinion meeting report","name":"articletitle","label":"Article Title"},{"value":"Journal of Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhep.2023.04.033","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier B.V. on behalf of European Association for the Study of the Liver.","name":"copyright","label":"Copyright"}]}}